Should Cannabinoids Be Recommended to Patients With Neuropathic Pain?
Two expert physicians with opposing viewpoints debate the risks and benefits of using cannabinoids for treating neuropathic and chronic pain.
Two expert physicians with opposing viewpoints debate the risks and benefits of using cannabinoids for treating neuropathic and chronic pain.
The study did not meet its primary endpoint of a 0.3 logMAR difference between treated and untreated eyes at week 48 , but it did demonstrate bilateral improvement of visual acuity from nadir to week 96.
Can nonviral gene delivery of hepatocyte growth factor reduce pain in patients with DPN and modify progression of the disorder?
When treating a patient with peripheral neuropathy and weakness of unknown origin, it is important for primary care providers to consider Charcot-Marie-Tooth disease as a differential diagnosis.
A chart review examines the effectiveness and tolerability of low-dose naltrexone to relieve symptoms of neuropathic corneal pain.
Researchers did a systematic review of guidelines covering a 13-year period to evaluate recommended rehabilitative interventions for neuropathic pain.
Investigators assessed the efficacy and tolerability of a high-concentration capsaicin 8% patch to treat diabetic peripheral nerve pain, either alone or in combination with standard oral therapies.
Researchers analyzed an antinociceptive mechanism in the sensory ganglia that they believe might potentially treat diabetic neuropathic pain.
Trigeminal neuralgia is a chronic neuropathic pain disorder that is important to include in the differential diagnosis of head or facial pain.
A digital health app designed to track and report on patient perceived pain relief and general well-being associated with spinal cord stimulation will be made available soon.